Page last updated: 2024-08-21

ethambutol and Hypoxia

ethambutol has been researched along with Hypoxia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Luukinen, H; Myllymäki, H; Niskanen, M; Parikka, M; Rämet, M	1
Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G	1

Other Studies

2 other study(ies) available for ethambutol and Hypoxia

Article	Year
Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish. Disease models & mechanisms, 2018, 03-13, Volume: 11, Issue:3 Topics: Animals; Antigens, Bacterial; Bacterial Load; Biomarkers; Dexamethasone; Disease Models, Animal; Ethambutol; Granuloma; Hypoxia; Immunosuppression Therapy; Lymphocyte Depletion; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; T-Lymphocytes; Tuberculosis Vaccines; Zebrafish	2018
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis	2019

Article

Year

Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish.

Disease models & mechanisms, 2018, 03-13, Volume: 11, Issue:3

Topics: Animals; Antigens, Bacterial; Bacterial Load; Biomarkers; Dexamethasone; Disease Models, Animal; Ethambutol; Granuloma; Hypoxia; Immunosuppression Therapy; Lymphocyte Depletion; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; T-Lymphocytes; Tuberculosis Vaccines; Zebrafish

2018

The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.

Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7

Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis

2019